Use

Jo-1 Antibody occurs most frequently (31 %) in patients with polymyositis, but has also been found in patients with dermatomyositis and overlap syndromes such as PM/SCL (polymyositis/scleroderma) or PM/SLE (polymyositis/systemic lupus erythematosus) ([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/questdemo/test/870456?utm_source=openai)).